Small Molecule Development & Manufacturting at Quotient Sciences

Live Webinar: Improve Drug Solubility from Formulation to Scale-Up

8 September 2026
Overview

Join us for our next webinar focused on addressing today's drug solubility challenges 

Register free on the Xtalks website.

Our next webinar will explore approaches including hot melt extrusion, spray-dried dispersions, lipid-based formulations and particle size reduction, while highlighting how early formulation decisions can reduce downstream development and manufacturing risks.

Quotient Sciences' speakers Robert Cornog, Senior Director, Product Development, and Dr. Andrew Parker, Executive Drug Development Consultant, will discuss a connected development strategy can help address drug solubility challenges from formulation selection through scale-up. They will be joined by Dr. Mark A. Krook, CMC & Early Drug Development at NGT Biopharma Consultants.

Attendees will gain insights into:

  • How to assess poorly soluble molecules and develop a fit-for-purpose formulation strategy aligned with clinical objectives
  • Key considerations for selecting between HME, spray drying, lipid-based and particle size reduction approaches
  • ASD Science and challenges for developing stable ASDs
  • How to reduce scale-up and technology transfer risks through early formulation and manufacturing planning
  • The value of integrating formulation development, manufacturing and clinical testing to accelerate decision-making and development timelines

Register free on the Xtalks website.

Register
Register now
Times

Tuesday, September 08, 2026

10am EDT  / 3pm BST  / 4pm CEST 

Location
Online - Live Webinar

Meet our speakers:

Robert Cornog

Senior Director, Product Development

Robert Cornog has over 26 years of experience in product development and process design. Across a broad range of dosage forms and ...

About Robert
Dr. Andrew Parker

Executive Drug Development Consultant

Dr. Andrew Parker has over two decades of experience in the pharmaceutical industry, spanning from preclinical development, throug...

About Andrew
Mark A. Krook, PhD

CMC & Early Drug Development Consultant at NGT Biopharma Consultants

Mark is a pharma executive with more than 35 years of experience, covering all aspects of small molecule CMC research and developm...

About Mark